Evidence map›Paper›PMID 41994604›Full record

ReviewExperimental and therapeutic medicine2026

Yuyu Zhang, Jinglan Wang, Wenting He, Tao Liu

Abstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuyu ZhangThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730030, P.R. China.
Jinglan WangGansu Provincial Key Laboratory of Environmental Oncology, Lanzhou, Gansu 730030, P.R. China.
Wenting HeThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730030, P.R. China.
Tao LiuThe Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730030, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Fc fragment of IgE receptor 1G (

Indexed as

Fc fragment of IgE receptor IgFc receptor γ chainimmunoreceptor tyrosine-based activation motifimmunotherapytumor immune microenvironment

Identifiers

PMID41994604
PMCPMC13082826

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.